645 related articles for article (PubMed ID: 9082768)
1. Immunological role of human palatine tonsil in Epstein-Barr virus persistence.
Hirao M; Harabuchi Y; Kataura A; Imai S; Osato T
Acta Otolaryngol Suppl; 1996; 523():158-60. PubMed ID: 9082768
[TBL] [Abstract][Full Text] [Related]
2. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
3. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
[TBL] [Abstract][Full Text] [Related]
4. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Epstein-Barr virus-specific cellular cytotoxicity in tonsillar lymphocytes].
Hirao M; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 1994 Mar; 97(3):473-84. PubMed ID: 8169745
[TBL] [Abstract][Full Text] [Related]
6. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
[TBL] [Abstract][Full Text] [Related]
8. Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
Berthomé M; Gallot G; Vivien R; Clémenceau B; Nguyen JM; Coste-Burel M; Vié H
Cancer Immunol Immunother; 2010 Dec; 59(12):1867-75. PubMed ID: 20809356
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
10. Detection of herpes simplex virus type 1 in addition to Epstein-Bar virus in tonsils using a new multiplex polymerase chain reaction assay.
Sahin F; Gerceker D; Karasartova D; Ozsan TM
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):47-51. PubMed ID: 17141448
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
[TBL] [Abstract][Full Text] [Related]
12. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
Wheatley GH; McKinnon KP; Iacobucci M; Mahon S; Gelber C; Lyerly HK
Surgery; 1998 Aug; 124(2):171-6. PubMed ID: 9706135
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
[TBL] [Abstract][Full Text] [Related]
16. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
[TBL] [Abstract][Full Text] [Related]
17. [Evidence for the persistence of Epstein-Barr-virus in the parotid gland (author's transl)].
Wilmes E; Wolf H
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):7-10. PubMed ID: 6261052
[TBL] [Abstract][Full Text] [Related]
18. [In vitro induced and expanded Epstein Barr virus-specific cytotoxic T lymphocytes can specifically kill nasopharyngeal carcinoma cells].
Chen LP; Huang JQ; Zhou TC; Zhang SX; Wang JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1431-3. PubMed ID: 18753079
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
